Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Primary: Effect on HbA1c over 48 weeks in insulin-treated patients with type 2 diabetes Secondary: Effect on glucose, total daily insulin dose, body weight, waist circumference, HDL-cholesterol, triglycerides - Safety, tolerability
Epistemonikos ID: 598f32ff0a529e42d748b005a651e7312c6cca32
First added on: May 04, 2024